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Summary 
 
 Two-thousand two-hundred fifty-two year-
ling steers (690 lb) were used to evaluate the 
effects of Optaflexx and days on feed on fin-
ishing steer performance and carcass charac-
teristics. Treatment groups included serial 
harvest dates of 150, 171, or 192 days.  Within 
each harvest date, steers either received Op-
taflexx (200 mg/steer daily of ractopamine-
HCl) for the final 28 days, or did not receive 
Optaflexx.  All steers were initially implanted 
with Revalor4-IS and were re-implanted with 
Revalor-S after 75 days on feed.   At harvest, 
muscle samples from the inside round were 
obtained for mRNA analysis of the β-
adrenergic receptors (AR). Optaflexx in-
creased daily gains, hot carcass weight, and 
ribeye area, and improved feed efficiency. Op-
taflexx did not affect dressing percentage, 
USDA yield grade, or quality grade.  Op-
taflexx did not change overall feed intake 
across the entire feeding period, but feed in-
take was increased during the 28-day period 
that steers received Optaflexx.  As expected, 
greater days on feed decreased daily gains, 
overall feed intake, and the number of yield 
grade 1 and 2 carcasses, and worsened feed 
efficiency. Also, greater days on feed in-
creased hot carcass weight, dressing percent-
age, and the number of prime and choice car-
casses, as well as the number of yield grade 4 
and 5 carcasses.  Increasing days on feed de-
creased the abundance of mRNA for β1-AR 
and β3-AR, and increased the abundance of β2-
AR mRNA.  Optaflexx had no effect on abun-
dance of mRNA for β1-AR or β3-AR, but it 
increased the abundance of mRNA for β2-AR.  
Optaflexx may affect expression of the β2-AR 
gene in skeletal muscle, which could impact 
the performance responses to Optaflexx feed-
ing in steers.  
 
Introduction 
 
 Previous results with Optaflexx, an ap-
proved β-adrenergic agonist for beef cattle, 
have demonstrated increased daily gains, im-
proved feed efficiency, increased carcass 
weight gain, and sometimes a slightly en-
hanced yield grade without detrimental effects 
on quality grade.  No studies have determined 
if the response to Optaflexx is affected by the 
length of the total feeding period.  Further, 
many studies report that the active ingredient 
of Optaflexx, ractopamine-HCl, functions as a 
β1-adrenergic receptor agonist.  Previous re-
search has suggested that exposure to a β-
 
         
 
 1Optaflexx is a registered trademark of Elanco Animal Health, Indianapolis, IN.  
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 4Revalor is a registered trademark of Intervet, Inc. 
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agonist, such as ractopamine-HCl, can affect 
the amount of the β-adrenergic receptor (AR) 
through which ractopamine mediates its bio-
logical effect.   
 
 The objectives of our study were to evalu-
ate the effects of feeding Optaflexx to yearling 
steers, harvested at three different harvest 
dates, on performance, carcass characteristics, 
and the abundance of β-adrenergic receptor 
mRNA in skeletal muscle tissue. 
 
Experimental Procedures 
 
 This study was a collaboration between 
Intervet, Inc. (Millsboro, DE), Cactus Re-
search, LTD, and Kansas State University.  
Two-thousand two-hundred fifty-two English 
× Continental steers (690 lb initial weight) 
were fed at Cactus Research, LTD.  Treat-
ments were arranged in a 3 × 2 factorial, and 
the experiment used a randomized complete-
block design.  Steers were blocked by arrival 
time, randomly assigned to treatments within 
block, and allotted to 24 pens, with 91 to 97 
steers per pen.  Pens of steers were assigned to 
harvest dates of 150, 171, or 192 days.  Within 
each harvest date, steers either received Op-
taflexx (200 mg/steer daily of ractopamine-
HCl) for the final 28 days, or did not receive 
Optaflexx (control).  Upon entering the 
feedyard, steers were implanted with Revalor-
IS (80 mg trenbolone acetate and 16 mg estra-
diol-17β), and 75 days later were reimplanted 
with Revalor-S (120 mg trenbolone acetate 
and 24 mg estradiol-17β).  USDA yield and 
quality grades were obtained at harvest.   
 
 At harvest, a muscle sample was collected 
from the inside round of four randomly se-
lected steers in each pen, snap-frozen, and 
shipped to the growth lab at Kansas State 
University.  Samples were stored at -112°F, 
and RNA was isolated from the muscle tissue 
of two steers in each group.  RNA was iso-
lated by using the TRI Reagent RNA isolation 
technique.  After isolation, RNA quality and 
quantity were measured; then the abundance 
of mRNA for β1-AR, β2-AR, and β3-AR was 
measured by using a reverse transcription-
polymerase chain reaction procedure. 
 
Results and Discussion 
 
 Feeding Optaflexx increased average daily 
gain by 4.6% and improved feed efficiency by 
3.8% (Table 1).  There was no overall change 
in dry matter intake in response to Optaflexx 
during the entire feeding period, but during 
the 28 days in which Optaflexx was fed, feed 
intake did increase by 3.5%, compared with 
that of controls (data not shown).  
  
Table 1.  The effects of Optaflexx on steer 
performance and carcass characteristics 
 Treatment 
Item Control Optaflexx 
Total gain, lba 570 601 
Dry matter intake, lb/day 19.50 19.64 
Daily gain, lb/daya 3.43 3.59 
Feed:gaina 5.70 5.49 
Dressing percentage 63.30 63.60 
Hot carcass weight, lba 816 834 
% carcasses > 949 lba 3.90 8.30 
Marbling score1 492 496 
Ribeye area, square inchesa 14.05 14.32 
USDA yield grade  2.8 2.8 
aOptaflexx, P ≤ 0.05. 
1500 = small/choice. 
 
 Optaflexx did not significantly alter dress-
ing percentage, but it increased hot carcass 
weight by 17 lb.  There were also a greater 
number of heavy weight carcasses when Op-
taflexx was fed.  Feeding Optaflexx increased 
ribeye area in cattle by 1.9%, but had no sig-
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nificant impact on the USDA quality and yield 
grades of the carcasses.    
 
 As expected, greater time on feed in-
creased hot carcass weight, dressing percent-
age, and the percentage of USDA Prime and 
Choice carcasses.  The number of yield grade 
4 and 5 carcasses also was increased as days 
on feed increased.  In addition, cattle perform-
ance worsened as time on feed increased; 
there were decreases in average daily gain and 
overall feed intake, and an increase in 
feed:gain (Table 2).  The inclusion of Op-
taflexx in the diet for 28 days before each of 
the harvest dates provided a positive perform-
ance response in each of the three groups (data 
not shown).  
 
Table 2.  The effects of days on feed on steer
performance and carcass characteristics 
 Days on Feed 
Item 150 171 192 
Total gain, lba 564 571 620 
Dry matter intake, 
   lb/day 19.7 19.7 19.3 
Daily gain, lb/daya 3.8 3.4 3.3 
Feed:gaina 5.18 5.79 5.83
Dressing percentagea 62.4 63.6 64.2 
Hot carcass weight, lba 790 823 862 
% carcasses > 949 lba 1.4 4.8 12.1 
Marbling scorea,1 477 493 511 
Ribeye area, 
   square inchesa 13.88 14.06 14.62
USDA yield gradea 2.7 2.9 2.8 
aDays on feed, P ≤ 0.05. 
1500 = small/choice. 
 
 Optaflexx had no effect on the abundance 
of β1-AR mRNA or β3-AR mRNA (data not 
shown), but there was an Optaflexx effect on 
the abundance of β2-AR mRNA (Figure 1).  
Also, the abundance of β1-AR mRNA and β3-
AR mRNA decreased as days on feed in-
creased (Figures 2 and 4).  Conversely, β2-AR 
mRNA abundance increased as days on feed 
increased (Figure 3).  The amount of β2-AR 
mRNA was nearly 200 times greater than the 
amount of β1-AR mRNA after 171 days on 
feed, and was approximately 160 times greater 
at 192 days on feed.   
 
 It is believed that ractopamine-HCl medi-
ates its response through the β1-AR. The data 
from this study show a decrease in β1-AR 
mRNA as cattle are on feed for a longer pe-
riod of time, but there was still a positive re-
sponse to Optaflexx for all three harvest dates.  
In addition, there was an increase in the abun-
dance of β2-AR mRNA as days on feed in-
creased, and feeding Optaflexx also increased 
the abundance of β2-AR mRNA.  The results 
from this study provide evidence that cattle 
preferentially express more β2-adrenergic re-
ceptors with increasing days on feed.  These 
changes could have dramatic effects on per-
formance if a high-affinity, β2 adrenergic ago-
nist (not ractopamine-HCl) was fed during this 
period. 
 
 Our data showed that Optaflexx feeding 
numerically increased the expression of the 
β2-adrenergic receptor and had no effect on 
the β1-adrenergic receptor.  Much in vitro re-
search suggests that a specific ligand down 
regulates its own receptor over time.  Our data 
does not support previous findings because the 
β1-adrenergic receptor was not affected, and 
the β2-adrenergic receptor abundance in-
creased, due to Optaflexx feeding. 
 
 
 
 
 23 
 
Control Optaflexx
0
100
200
P=0.09
Treatment
Ar
bi
tr
ar
y 
un
its
, M
ill
io
ns
 
150 171 192
0.0
2.5
5.0
7.5
b
b
a
Days on feed
Ar
bi
tr
ar
y 
un
its
, M
ill
io
ns
a,b P<0.05
 
 
                                                                          
 
 
 
150 171 192
0
100
200
300
a a
b
a, b P<0.05
Days on feed
Ar
bi
tr
ar
y 
un
its
, M
ill
io
ns
 
150 171 192
0
5
10
15
b
b
a
Days on feed
Ar
bi
tr
ar
y 
un
its
, M
ill
io
ns
a, b P=0.0008
  
 
 
 
 
 
Figure 1.  Main effects of Optaflexx on β2-
adrenergic receptor mRNA. 
Figure 2.  The abundance of β1-adrenergic 
receptor mRNA at three different harvest 
dates. 
Figure 3.  The abundance of β2-adrenergic 
receptor mRNA at three different harvest 
dates. 
Figure 4. The abundance of β3-adrenergic 
receptor mRNA at three different harvest 
dates. 
